Overview
- 7 FDA inspections are on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2026-06-24.
At a glance
Inspections
7
Form 483s
1
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 17 Jun 2026 – 24 Jun 2026 | Biologics | Clean | |
| 5 Aug 2019 – 9 Aug 2019 | Biologics | Clean | |
| 26 Jul 2017 | Biologics | Clean | |
| 10 Jun 2015 – 12 Jun 2015 | Biologics | Clean | |
| 16 Nov 2012 | Not recorded | Clean | |
| 15 Oct 2010 | Not recorded | 483 | View 483 → |
| 14 Nov 2008 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Michelle Paxon1 insp.
Nimmy Mathews1 insp.
Maira P Brading1 insp.
Lourdes R Genera1 insp.
Scott T Ballard1 insp.
Tracy J Washington1 insp.
Karlton T Watson1 insp.
Jodi M Gatica1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 606.100(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 606.65(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 640.21(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Carter BloodCare's 1 Form 483
Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat